Therapeutic Innovations in Ovarian Cancer Treatment: The New England Perspective

John O. Schorge^1*, Tracilyn R. Hall¹, Xun C. Zhou², Amy J. Bregar³, Rosemary Foster⁴, Christopher J. Darus⁵, Loyd A. West⁶ and Cheung Wong⁷

¹Vincent Gynecologic Oncology Service, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

²The Hospital of Central Connecticut, New Britain, Connecticut, USA

³Program in Women’s Oncology, Women & Infants Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA

⁴Vincent Center for Reproductive Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

⁵Maine Medical Center Cancer Institute, Portland, Maine, USA

⁶Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA

⁷University of Vermont Medical Center, Burlington, Vermont, USA

^*Corresponding Author: John O. Schorge, MD, Vincent Gynecologic Oncology Service, Massachusetts General Hospital, Harvard Medical School, Yawkey Center-9E, 55 Fruit St, Boston, MA 02114, USA, Tel: 617-724-4800 Email: